CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells

Authors

Diane D. Mao, Washington University School of Medicine in St. Louis
Ryan T. Cleary, Saint Louis University
Amit Gujar, The Jackson Laboratory in Genomic Medicine
Tatenda Mahlokozera, Washington University School of Medicine in St. Louis
Albert H. Kim, Washington University School of Medicine in St. Louis

Journal

PLoS One

Publication Date

1-1-2022

Volume

17

Issue

6

First Page

e0270251

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0270251

Rights and Permissions

Mao DD, Cleary RT, Gujar A, Mahlokozera T, Kim AH (2022) CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells. PLOS ONE 17(6): e0270251. https://doi.org/10.1371/journal.pone.0270251. © 2022 Mao et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Mao, Diane D.; Cleary, Ryan T.; Gujar, Amit; Mahlokozera, Tatenda; and Kim, Albert H., "CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells." PLoS One. 17, 6. e0270251 (2022).
https://digitalcommons.wustl.edu/oa_4/84